Clinical Trial Update: Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on monoclonal antibody conditioning for allogeneic stem cell transplantation in patients with inherited metabolic storage diseases. The Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inherited Metabolic Storage Diseases

Drugs mentioned

• Monoclonal antibody conditioning agent

Snippet

Sponsor: Baylor College of Medicine | Conditions: Inherited Metabolic Storage Diseases | Phase 1, Phase 2 | Status: TERMINATED